All Webinars

Researchers are tapping into the potential of noncoding RNA in the blood to enhance cancer diagnostics. 

How do forever chemicals impact cardiovascular health in postmenopausal women?

Learn how to catch drugs’ hidden cardiotoxicity risks early in their development.

Learn about the pathways and strategies to bring medical device innovations to life. 

Advances in artificial intelligence enable high throughput compound profiling and cell viability analysis. 

Scientists discover an ultra-rare monoclonal antibody directly from patients with autoimmune diseases.

New chemical synthesis technologies speed up the identification and optimization of promising drug candidates.

Automating liver cell counting adds a new layer of support for drug metabolism studies. 

Evaluating drug toxicity to development and reproduction is a critical component of drug safety assessment. 

Researchers develop sensitive blood-based diagnostics to detect tiny traces of cancer. 

Organic molecules with novel biological properties offer new ways to eliminate multidrug-resistant bacteria. 

Researchers harness pharmacogenomics to understand why individual patients react differently to opioids for pain relief. 

Diverse genetic and environmental factors such as stress or UV exposure can spark autoimmune diseases. 

Brain organoids serve as avatars for studying human neurobiology and advancing drug discovery for neurological disorders. 

A groundbreaking fusion of flow cytometry and cell imaging pushes the limits of cell examination and sorting. 

T cells have long held the title of the ideal immune cells for CAR therapy, but recent discoveries are opening new possibilities for other immune cells.

How are scientists incorporating oncolytic viruses into the current cancer treatment landscape? 

Artificial intelligence is helping researchers fill in critical gaps in medical treatment by identifying new drug targets for more precision medicine solutions.

AI simulates how cancer cells respond to therapy, guiding optimal treatment strategies.

Slight modifications to glycoproteins reveal critical insights into disease onset, state, and progression, making them a wellspring for biomarker discovery.